BioPhage Therapeutics

BioPhage Therapeutics Limited is a UK-based company with strong expertise in the clinical development, registration, and marketing of therapeutic drug products. On April 4, 2017, Intralytix and BioPhage Therapeutics partnered to develop and commercialize a topical phage therapy for human wounds infected or colonized with Staphylococcus aureus.